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CHAPTER I 
 
INTRODUCTION 
 
Motivation and objectives 
 Recent studies in our lab have shown that organotypic raft cultures have Raman 
spectra closely mimicking those of actual tissue, particularly epithelial tissues like cervix 
and skin.  Other studies in our lab have demonstrated that Raman spectroscopy can 
discriminate among basal cell carcinoma (BCC), squamous cell carcinoma (SCC), non-
normal benign (e.g. scar), and normal skin in vivo.  Although the neoplasms tend to arise 
in or invade fairly deeply in the epidermis, the optimal depth of measurement for 
discrimination purposes is about 40 µm.  The primary objective of this work was to 
determine how the location and concentration of SCC cells within raft cultures affect the 
Raman spectral signatures of the rafts.  Further goals were to investigate the depth 
dependence of the cancerous cell locations and measurement sites, and to correlate 
spectroscopic findings with histology. 
 
Specific aims 
 The following specific aims were developed to guide my research regarding the 
objectives stated above: 
 
1.  Modify raft cultures to include SCC cells in the dermis.  Raft cultures were previously 
always constructed with normal dermis layers and either normal or dysplastic epidermal 
1 
layers, so my first task was to figure out how to make rafts with cancerous cells in their 
stromal layers. 
 
2.  Obtain and compare Raman spectral signatures of rafts with dysplastic cells in their 
stroma to previous raft constructs.  Raman spectroscopy has previously been used in our 
lab to examine normal raft cultures and rafts with dysplastic epidermal layers, but 
spectral signatures from those types needed to be compared with spectral signatures of 
rafts with dysplastic cells in their stroma. 
 
3.  Determine the depth dependence of the source of Raman spectral discrimination in the 
earlier in vivo study.  The epidermal and stromal layers of the rafts were separated and 
measured to determine whether distal disease could be detected near the surface. 
 
4.  Compare spectroscopic findings with histology.  Biopsy is still the gold standard of 
skin cancer diagnosis, so Raman spectral measurements have to be evaluated alongside 
histological findings of the raft cultures to verify the tissue status. 
 
 As a result of these specific aims, we expected to find that raft cultures could still 
be reliably produced with SCC cells in the dermal layer, and that the spectra of these rafts 
would at least closely resemble those of rafts with SCC cells in the epidermis and a 
normal dermis.  We believed that stromal disease would be detected in the epidermal 
layers, with histology showing that layer to still look fairly normal. 
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CHAPTER II 
 
BACKGROUND 
 
 Skin cancer is a major problem in the United States that continues to get worse, as 
the incidence increases by 5-10 % each year.  The various major forms of skin cancer: 
melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC), account for 
over half of the cancer cases in the US.  The nonmelanoma cancers (BCC and SCC) 
account for about 95 % of the 1.3 million new cases of skin cancer each year, and BCC 
comprises the majority of these cases with 75-80 %, while SCC comprises 15-20 % of 
cases.  Although malignant melanoma accounts for only 4 % of new skin cancer cases 
each year, it is responsible for nearly 80 % of the estimated 10,000 deaths each year from 
skin cancer.1
  
Normal Skin Histology 
 A basic understanding of normal skin histology is essential for further discussion 
on skin cancer.  As seen in Figure 1, skin is typically divided into three layers: the 
epidermis, dermis, and hypodermis, although this bottom layer is rarely important in skin 
cancer.  The dermis, usually 0.3 to 3 mm thick, is further divided into the papillary and 
reticular layers as seen in Figure 1.1.  The papillary layer consists primarily of small 
blood vessels and fine collagen and elastic fibers, and the reticular layer contains the 
larger vascular plexus as well as compact collagen and thick elastic fibers.  In both layers, 
fibroblasts are the primary cell, and they produce much of the extracellular matrix.2
3 
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Figure 1.1  Histology of normal skin3
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2  Closer look at the epidermis3
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 The epidermis is usually around 0.1 mm thick, though it can grow to about 1 mm 
on the palms and soles.  It is further divided into five layers: the strata basale (or 
germinativum), spinosum, granulosum, lucidum, and corneum, going from bottom to top 
as seen in Figure 1.2.  The stratum basale contains the basal cells, or germ cells, that 
continually divide to replace cells that have undergone keratinization, which is the 
process of keratinocytes flattening, losing their nuclei, and accumulating keratin before 
dying to form the water-proof stratum corneum.  Keratin filaments, which attach at 
desmosomes and are crosslinked by fillagrin to form large aggregates, are essential for 
the structural stability and integrity of the epithelium as the keratinocytes mature and 
move outward. The stratum basale also contains the pigment-producing melanocytes and 
sensory Merkel cells.  The only other cell type in the epidermis is the Langerhans cell, 
which is involved in immune functions in the middle layers of the epidermis.2,4   
 The area between the top two skin layers is referred to as the dermoepidermal 
junction, which consists of the lamina lucida and lamina densa.  The lamina lucida is in 
contact with the epidermis, and it consists of anchoring proteins such as laminin 6, p105, 
and p200.  The thicker lamina densa contacts the dermis and consists primarily of laminin 
5 and BP180.  Other components typically found in the region include BP240, collagen 
IV, and α6β4 integrin.2
 
Basal Cell Carcinoma 
 The most common cancer in humans, basal cell carcinoma is defined as a 
malignant neoplasm derived from nonkeratinizing cells that originate in the basal layer 
(stratum basale) of the epidermis.  BCC can invade and damage surrounding tissues, but 
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it metastasizes in less than 0.5% of cases.  The biggest risk factors for BCC include 
ultraviolet light exposure, fair skin, Celtic ancestry, an inability to tan, and exposure to 
ionizing radiation.2  Development of BCC can take from several months to several years 
after the initiating event to become clinically presentable.  More than 80% of all BCCs 
occur on the head and neck, though not always in areas of greatest UV exposure, and men 
and older people are affected more than women and younger people.  Over 99% of cases 
can be cured, but there is a 45% chance for developing another BCC within 3 years, and 
the 5 year recurrence rate is around 8%.5
 A number of histologic features define BCC.  The cells are basophilic, arise from 
and resemble basal cells of the epidermis, have increased nucleus to cytoplasm ratios, and 
lack prominent nucleoli and intercellular bridges.  The tumors tend to form nests with 
basal layers surrounding them, a condition known as palisading, which is shown in 
Figure 1.3.  A mucinous stroma forms around the tumor parenchyma, and the stroma  
 
 
 
 
 
 
 
 
 
Figure 1.3  Nodular BCC demonstrating palisading around tumor nests3
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tends to retract from tumor islands upon examination, creating peritumoral lacunae.  A 
BCC cannot grow well without its stroma, so only the most aggressive tumors can 
metastasize.6
  There are five major clinical subtypes of BCC: nodular, pigmented, superficial, 
morpheaform, and fibroepithelioma of Pinkus.  Nodular BCC is the most common form, 
and it presents as a translucent papule or nodule, often with telangiectasias and a rolled 
border.  Histopathologically, nodular BCC looks like Figure 1.3 with tumor nests and 
palisading.  Pigmented BCC is any BCC with a large amount of melanin, though this 
typically occurs with nodular BCC.  Superficial BCC, as shown in Figure 1.4, consists of 
tumor cells budding down into the dermis and palisading.  It can resemble eczema or  
 
 
 
 
 
 
 
Figure 1.4  Superficial BCC from cross section5
 
 
 
psoriasis, and it is the least aggressive BCC, typically found on the trunk.  In contrast to 
superficial BCC, morpheaform, or infiltrative BCC, is quite aggressive and is likely to 
recur since it is often larger than it appears on the surface.  It consists of tumor cells 
tightly packed in a dense stroma that can extend deep within the dermis, as shown in 
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Figure 1.5.  Morpheaform BCC often resembles a scar, and it can even develop from an 
old scar.  Fibroepithelioma of Pinkus appears as long strands of interwoven basiloma 
cells embedded in fibrous stroma.2,5   
  
Figure 1.5  Histology of morpheaform BCC2
 
 
 
 
 
 
 
 On a smaller scale, BCC cells express low molecular weight keratin peptides but 
not high molecular weight ones.  In this manner, they resemble both basal epidermal and 
follicular epithelial cells.  The tumor stroma contains the usual laminin and collagen IV, 
but the BP240 is typically not present around tumor islands.  In addition, BCC cells have 
sparse mitochondria, granular endoplasmic reticula, prominent desmosomes, and 
abundant tonofilaments.7
 
Squamous Cell Carcinoma 
 SCC is defined as a neoplasm arising from suprabasal keratinocytes in the 
epidermis, often from the stratum spinosum, and invading downward through the dermis.  
Although BCC is much more common than SCC, the greater ability of SCC to 
metastasize (0.5-6% of cases metastasize to regional lymph nodes 1 to 3 years after initial 
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diagnosis) makes it responsible for most nonmelanoma skin cancer deaths.5  The 
incidence of SCC increases drastically with age, and it often develops out of precursor 
legions such as actinic keratoses and Bowen's disease, or SCC in situ.  Other primary risk 
factors include UV and ionizing radiation exposure, fair skin, thermal burns or other 
scars, certain strains of human papilloma virus, and mutations in the tumor suppressor 
p53 and apoptosis-inhibitor Bcl-2, inhibiting the former and activating the latter.2  SCC 
can be found in highly sun-exposed areas as well as on the scalp and on the back of the 
hands, two places where BCC is rarely found.5
 SCC often presents as a firm, flesh-colored or erythematous, keratotic papule or 
plaque, though pigmentation, ulcer, and a cutaneous horn may also be present.  The 
histopathology of a typical SCC is shown below in Figure 1.6.  The defining 
characteristic is the presence of atypical keratinocytes extending beyond the basement 
membrane into the dermis, though they can appear as single cells, nests of cells, or a 
single mass.  The atypical cells themselves are characterized by increased mitoses,  
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Figure 1.6  Standard histology section of invasive SCC9 
aberrant mitotic figures,nuclear hyperchromasia, and loss of intercellular bridges.  
Grading of the tumor is based on degree of differentiation of the cells, where more 
aggressive tumors are less differentiated.  This dedifferentiation is observed as a 
reduction in keratin production and loss of intercellular bridges.  Other signs of an 
aggressive tumor include poorly defined margins between the tumor and normal stroma, 
a size larger than 2 cm, invasion greater than 4 mm deep, and an origin at the lips or in 
scar tissue.  Histologic subtypes of SCC include adenoid, clear cell, spindle cell, signet-
ring cell, verrucous carcinoma, and keratocanthoma.2
 A number of studies have been performed to investigate the biochemical changes 
in and around SCC.8-10  Active remodeling of the ECM into a tumor stroma has been 
indicated as a key step in the invasion process.  Fibroblasts migrate toward the solid 
tumor through an unclearly defined mechanism possibly involving type I collagen 
expression, where they then differentiate toward becoming myofibroblasts.  Poorly 
differentiated SCCs show diffuse localization of myofibroblasts, whereas more 
differentiated SCCs show only a local distribution of them.  Type I collagen synthesis has 
shown a very high degree of correlation with invasive SCC tumor fronts, presumably as 
the body's effort to encapsulate the tumor and prevent further growth.  Despite this 
increase in collagen I synthesis, the tumor stroma of the more aggressive neoplasias 
actually have a reduced and disordered collagen content.8  This disorder of the matrix 
proteins is generally attributed to various collagenases and matrix metalloproteinases 
(MMPs), especially MMP-2 and MMP-9, that are necessary for the invasion process.11   
 Other studies have examined the role of internal biochemical pathways in SCC.  
The levels of extracellular Ca2+ play a large role in keratinocyte differentiation, so 
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accordingly protein kinase C (PKC) is a major player in SCC.  PKCα, one particular 
isozyme, has been shown to be responsible for many of the characteristic biochemical 
changes in SCC, including inhibition of keratin 1 and 10 expression and up-regulation of 
loricrin, filaggrin, and transglutanimase-1.9  Other specific biochemical changes in SCC 
include upregulation of keratins K13, K14, and K19,10 abnormalities in chromosomes 6 
and 7, loss of TGFβ1, and upregulation of α6β4 integrin.9
 
Current Diagnosis and Treatment 
 Diagnosis of a nonmelanoma skin cancer requires a biopsy to be taken and then 
read by a trained pathologist.  For both BCC and SCC, if the lesion is primarily 
superficial, a shave biopsy may be sufficient; if the lesion appears to involve deeper 
tissue, then a punch biopsy is required.12  This method can be slow, subjective, and 
painful, so a number of non-invasive diagnostic techniques are being investigated.  CT 
and MRI can be used to examine the extent of disease, especially in sensitive areas like 
the head and neck.  MRI is better suited for looking at soft tissue invasion, while CT is 
better for detecting bone invasion.  Ultrasound and nuclear medicine techniques, 
primarily SPECT and FDG-PET, can also be used to help distinguish inflammation and 
necrosis from recurrent tumor.6   
 The most common treatment methods for BCC and SCC include 
electrodessication and curettage (ED&C), cryosurgery, surgical excision, radiation 
therapy, and Mohs micrographic surgery.  The first four are fairly self-explanatory; Mohs 
micrographic surgery is a more complex process.  A thin horizontal section is cut from 
the entire surface of the gross tumor, stained, and divided into quadrants from which a 
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map is drawn.  The excised pieces are then frozen sectioned and microscopically 
examined to note the locations of cancer on the map.  Deeper horizontal sections are then 
taken only from quadrants that contained cancerous cells, and this process is repeated 
until none of the sections shows any signs of cancer, indicating complete removal.12   
 The treatment chosen for BCC depends on the subtype and location of the tumor.  
ED&C is the treatment of choice for small nodular lesions on the face and any tumors on 
the trunk or extremities, and surgical excision can be used on these as well but is more 
often reserved for recurrent cases.  Cryotherapy is generally limited to superficial tumors 
on the trunk, and radiation therapy is reserved for inoperable tumors.  Mohs micrographic 
surgery is used for any tumors in sensitive areas of the face and can be used for recurrent 
cases elsewhere.12
 Treatment protocols for SCC are similar to those for BCC but have some 
differences.   ED&C is typically used for SCC in situ and other superficial cases, and 
surgical excision is used for other accessible primary lesions.  Cryosurgery is generally 
limited to treating pre-cancerous lesions, and radiation therapy is again used only for 
inoperable cases.  Mohs micrographic surgery is used as it is for BCC and for other 
aggressive tumors.  Alternative treatments sometimes applied to SCC include CO2 laser 
excision, photodynamic therapy, and topical application of the chemotherapeutic 5-
fluorouracil on pre-cancerous lesions only.12  
 
Optical spectroscopy 
 There are drawbacks to current diagnostic methods for skin cancer.  They rely on 
initial visual inspection, which can be error-prone (especially with regard to false 
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positives), and tissue biopsy, which is a subjective, relatively costly, and slow procedure.  
Biopsy can also be more painful than the actual treatment procedure.  There is thus a 
need for an accurate, real-time, non-invasive diagnostic tool.  Various methods of optical 
spectroscopy have been used in attempts to achieve this goal, particularly fluorescence, 
elastic scattering, and Raman spectroscopy.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7  Jablonski diagram illustrating physical principles of common optical 
spectroscopic modalities. Si refers to electronic energy levels; vi to vibrational ones. 
Dashed line represents a virtual excited state. 
 
 
 
Fluorescence and diffuse reflectance 
 As shown in Figure 1.7, fluorescence involves absorption of a photon, internal 
conversion (heat dissipation), and then re-release of a photon of lower energy.  In tissue, 
autofluorescence signals from certain compounds like NADH, collagen, and flavins 
provide information about the metabolic or biochemical status of the tissue, and can thus 
distinguish between healthy and diseased states. Elastic, or Rayleigh, scattering involves 
an incident photon getting its path changed without losing or gaining any energy.  This 
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technique, also known as diffuse reflectance, provides morphological information about 
the tissue, such as number and size of scattering nuclei.  Since these two techniques both 
have strong signals and provide complementary information, they are often combined to 
maximize diagnostic potential.  Fluorescence and diffuse reflectance have been applied to 
cancer detection in many areas of the body, including cervix,13-15 skin,16, 17 breast,18-20 and 
brain.21, 22  While these techniques have experienced success in certain areas, the broad 
peaks can limit their ability to distinguish among many different classes of disease,23 and 
especially in skin, pigmentation and external chemicals can severely limit the penetration 
depth of the UV excitation source. 
 
Raman spectroscopy 
 Raman spectroscopy utilizes its namesake inelastic scattering, which occurs when 
an incident photon causes a scattering molecule to enter a virtual excited state, and then 
return to a ground state either higher or lower than the original through the emission of 
another photon, as seen on the right side of Figure 1.7.  Raman Stokes scattering occurs 
when the scattered photon has less energy than the incident photon, while Raman Anti-
Stokes scattering occurs when the scattered photon has more energy than the incident 
photon.  In contrast to fluorescence, which involves transitions between electronic energy 
levels, Raman scattering exploits smaller transitions between vibrational energy levels.  
This less intense signal requires a powerful laser source and a sensitive detector, and the 
much stronger fluorescence must be subtracted from the raw spectrum as well. 
 A Raman spectrum is a plot of scattered light intensity versus the frequency shift 
of the scattered photon, making it independent of excitation wavelength.  The frequency 
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shift is expressed in units of wavenumber, which is the reciprocal of the wavelength, so it 
is proportional to frequency.  The spectrum consists of a series of peaks, each of which 
represents a different vibrational mode of the scattering molecule.  These peaks are 
narrow and highly specific to a particular chemical bond, so each molecule has a unique 
spectrum, or “fingerprint,” associated with it from about 700 to 2000 cm-1.  Many 
biological molecules have distinguishable spectra, so one can determine the gross 
biochemical composition of a tissue from its Raman spectrum.  One particularly relevant 
biochemical change previously discussed for cancer cells is an increase in the nucleic 
acid content concomitant with increased proliferation and genetic instability.  This 
change, among others, can be detected with Raman spectroscopy.24, 25 
 Raman spectroscopy was historically used in analytical chemistry to determine 
chemical structures or the presence of certain molecules, and it has only been in the last 
ten or twelve years that it has become a more popular choice for studying tissue.  The 
majority of studies have been in vitro, attempting to distinguish normal from cancerous 
tissue in areas like cervix26, breast,27-29 bladder and prostate,27,30 lung,31 and the GI tract.27  
Many have written of the challenges of bringing Raman to in vivo applications,32, 33 but it 
has been successfully applied to cervix,34 GI tract,35, 36 and breast.37 
 Human skin, because of its ease of access, has seen a great deal of study by 
Raman spectroscopy.  Earlier in vitro studies used mostly FT-Raman to examine skin 
structure38-43 and to attempt to distinguish normal from cancerous tissues.44, 45  The 
instrumentation for FT-Raman prevents its use in a clinical setting, so a more recent in 
vitro study used traditional Raman spectroscopy to distinguish BCC from normal tissue 
by producing two-dimensional Raman images.46  Many in vivo studies have been 
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performed as well, especially examining carotenoid content of the skin,47-50 which is 
thought to play a role in defense against malignancy.  Other fiber probe-based in vivo 
studies have investigated various structural and biochemical aspects of the skin,51-54 and 
several groups have used Raman spectra in combination with fluorescence or advanced 
multivariate statistical techniques to enhance discrimination between normal and 
cancerous tissues.55-57   
 Since the skin is a stratified tissue, a major goal for dermatological applications is 
having depth-resolved data.  To this end, several groups have applied confocal Raman 
spectroscopy or Raman microspectroscopy to gather data from only a thin layer of the 
skin at a time.  These techniques have been applied in vivo both to determining molecular 
concentration profiles58-60 and to discriminating between normal skin and BCC.61  In our 
lab, a previous study used confocal Raman spectroscopy to distinguish among SCC, 
BCC, and non-normal benign tissues (e.g. scar) when comparing the spectra to their 
respective normal spectra.62 
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CHAPTER III 
 
USING ORGANOTYPIC RAFT CULTURES TO UNDERSTAND THE BIOLOGICAL 
BASIS OF RAMAN SPECTRA OBTAINED FROM SKIN 
 
Abstract 
 Recent studies have shown that organotypic raft cultures have Raman spectra 
closely mimicking those of actual tissue, particularly epithelial tissues like cervix and 
skin.  Other studies in our lab have demonstrated that Raman spectroscopy can 
discriminate amongst basal cell carcinoma (BCC), squamous cell carcinoma (SCC), non-
normal benign, and normal skin in vivo.  Although these neoplasms tend to arise in or 
invade fairly deeply in the epidermis, the optimal depth of measurement in that study for 
discrimination purposes was about 40 µm.  The primary purpose of this work was to 
determine how the depth and concentration of SCC cells within raft cultures affect the 
Raman spectral signatures of the rafts.  In this manner, raft cultures proved to be useful 
models in elucidating the biological basis of Raman spectra obtained in vivo by 
controlling where cancerous cells were found within the model during measurements.  
Raft cultures were constructed with a range of concentrations of SCC cells in the stroma 
(0.2x to 1x relative to fibroblast concentration) and in the epidermis, and measurements 
were taken at multiple time points with a macroscopic Raman probe system.  The spectra 
collected with the probe system successfully differentiated normal from cancerous rafts, 
and they showed that the location and concentration of SCC cells did not have a 
significant effect on the spectral signatures.  In addition, data gathered from the separated 
epidermal vs. stromal layers, combined with histology, support the hypothesis that 
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Raman spectroscopy can detect biochemical changes associated with malignancy before 
such changes are evident via histology. 
 
Introduction 
 Skin cancer is a major problem in the United States that continues to get worse, as 
the incidence increases by 5-10 % each year.  The various major forms of skin cancer: 
melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC), account for 
over half of the cancer cases in the US.  The nonmelanoma cancers account for over 95 % 
of the 1.3 million new cases of skin cancer each year, and BCC comprises the majority of 
these cases with 75-80 %, while SCC comprises 15-20 % of cases.  Although malignant 
melanoma accounts for only 4 % of new skin cancer cases each year, it is responsible for 
nearly 80 % of the estimated 10,000 deaths each year from skin cancer.1  BCC arises from 
the basal layer of the epidermis, about 100 µm to 1 mm below the surface of skin, so the 
cells are non-keratinizing and remain relatively undifferentiated.  It can invade and 
damage surrounding tissue, but it very rarely metastasizes.  SCC arises from suprabasal 
keratinocytes, often in the stratum spinosum of the epidermis.  It tends to invade 
downward, and it will occasionally metastasize.2
 Current diagnostic methods for skin cancer rely on initial visual inspection, which 
can be error-prone (especially with regard to false positives), and tissue biopsy, which is 
a subjective, relatively costly, and slow procedure.  Biopsy can also be more painful than 
the actual treatment procedure.  There is thus a need for an accurate, real-time, non-
invasive diagnostic tool.  Given the accessibility of the skin, several modalities of optical 
spectroscopy have been used in efforts to achieve this goal, but Raman spectroscopy has 
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seen the most success.  Many earlier studies confirmed the ability of Raman to determine 
molecular composition profiles,3-5 structures of skin components,6-9 and water content of 
the skin10.  Knudsen et. al showed that Raman spectra of skin are reproducible for the 
most part both within and between patients.11  The roles of carotenoids12-14 and lipids15-18 
in skin disease have been investigated with Raman as well.  Several papers have reported 
the ability to distinguish BCC from normal tissue with great success,19-21 but only limited 
attempts have been made to discriminate among more than two classes of skin disorders, 
with varying degrees of success.22, 23
 Recognizing the need for multi-class discrimination, our recent in vivo 
experiments24 have demonstrated the ability of Raman spectroscopy to differentiate 
among normal, non-normal benign (e.g. scar tissue), BCC, and SCC tissues in human 
skin.  The non-melanoma skin cancers arise from fairly deep within the epidermis and 
tend to invade downward, but the most useful depth of measurement in these experiments 
turned out to be 40 µm below the surface, which is usually in the middle of the epidermis.  
One possible explanation for these findings is the presence of so-called malignancy 
associated changes (MACs), which refer to biochemical changes, such as chromatin 
rearrangement, in visually normal cells in the vicinity of a tumor that can be detected 
with ultra sensitive techniques like high resolution cytometry.  This idea was first 
proposed over 40 years ago,25-27 and more recent studies of tissues such as lung,28-30 
cervix,31-33 and breast34-36 have supported the idea.  Additionally, Roy et. al. have shown 
the ability of enhanced elastic scattering spectroscopy to detect pre-malignant changes in 
colon tissue of rats, mice, and humans.37, 38  Since the true mechanism underlying Raman 
classification of skin types in our study is not known, though, there is a need to discover 
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the natures and locations of the sources of the spectral variations that allow 
discrimination. 
 Organotypic raft cultures are in vitro tissue models of the human skin containing 
collagen and fibroblasts to model the dermis (stroma) and layers of differentiated 
keratinocytes to model the epidermis.  The Raman spectra of these raft cultures have been 
shown to replicate the spectra of normal epithelial tissues quite faithfully, and the spectra 
of raft cultures with cancerous cells replacing keratinocytes also correspond to spectra of 
cancerous tissue samples.  In these raft studies, the majority of the useful spectral 
variation came from the epidermal layers.39  The primary purpose of this in vitro study 
was to determine how the location and concentration of SCC cells within raft cultures 
affect the Raman spectral signatures of the rafts, both macroscopically and within 
individual layers.  Normal rafts, rafts with SCC cells in the epidermis and a normal 
stroma, and rafts with SCC cells in the stroma and a normal epidermis were constructed, 
and Raman spectra were obtained at multiple time points of the intact rafts and of the 
separated epidermis and dermis layers.  Raft cultures were processed for histology as well 
to provide morphological information. 
 
Materials and Methods 
 
Raft culture construction 
 Normal raft cultures and rafts with SCC cells (human epidermoid squamous cell 
carcinoma, A-431) in the epidermis layer only were constructed as described in reference 
39.  Briefly, normal human dermal fibroblasts (NHDF) were mixed with a concentrated 
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collagen solution, reconstitution buffer, and concentrated high-glucose Dulbecco's 
Modified Eagle's Medium (DMEM) in 24 well plates to form the stromal layer.  This 
mixture was incubated at 37 degrees Celsius in 5 % CO2 and 95 % humidity for 24 hours, 
after which normal human epidermal keratinocytes (NHEK) or SCC cells were added to 
form the epidermal layer.  The rafts were incubated for another 24 hours, and if they had 
not contracted away from the edge of their plate wells at this time, a thin spatula was run 
around the edge to aid in contraction.  They were incubated for another 24 hours and then 
placed on metal grids in 60 mm petri dishes.  A 50/50 mixture of DMEM and the 
appropriate media for the epidermal cells was used to feed rafts from below only, and this 
media was changed every other day.  For rafts with SCC cells in the stroma layer, SCC 
cells were mixed with normal fibroblasts at varying concentrations while keeping the 
total number of cells in the stroma constant.  Only normal keratinocytes were used in the 
epidermal layer as for normal rafts.  In the initial study, the concentrations of SCC cells 
relative to normal fibroblasts in the stroma for dysplastic rafts were 1x, .6x, .4x, and .2x.  
Based on initial studies, in subsequent studies SCC cell to NHDF ratios of 1x and .5x, 
were used.  Two to four rafts of each SCC cell concentration were made for each 
experiment, and four normal rafts were constructed as controls each time. 
 
Raman measurements 
 Raman spectral measurements were obtained as described in reference 39 using 
the probe system shown below in Figure 2.1, but with an integration time of five seconds.  
The system consists of a 785 nm diode laser outputting 80 mW at the sample, coupled to 
a single 400 µm excitation fiber.  A bandpass filter at the probe tip cleans up the laser  
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Figure 2.1  Probe system used to gather Raman spectra.  NF, notch filter at 785nm; BP, 
bandpass filter at 785 nm; CCD, charge-coupled device 
 
 
light entering the sample, and seven 300 µm fibers collect the backscattered Raman 
signal, with notch filters at 785 nm to block elastically scattered photons or specularly 
reflected laser light.  The collection fibers then run to a spectrograph to separate the 
collected light by wavelength and a CCD to capture the spectra.  The CCD is connected 
to a computer to control its operations and record the gathered spectra.  Raman 
measurements were taken at multiple time points as well – at 5, 12, 19, and 26 days 
following the transfer to the air-liquid interface in the initial study, and at 15 and 20 days 
for subsequent studies (10 day measurements were initially done as well but eventually 
dropped).  Two measurements were taken from each raft at different locations. After the 
last time point, one or two rafts of each type were fixed in 10% formalin for histological 
processing, and the remaining rafts had their epidermal and stromal layers separated and 
measured as previously described. 
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Data processing and analysis 
 Collected Raman spectra were processed as in reference 39.  In brief, this 
involved calibrating the wavenumber axis with measurements of neon-argon lamp, 
acetaminophen, and naphthalene standards, binning the wavenumber axis to 3.5 cm-1, and 
smoothing the data with a second order Savitzky-Golay filter.  The background 
fluorescence was removed with a modified fifth-order polynomial fit, and spectra were 
normalized to their overall mean intensity to account for any fluctuations in overall 
intensity.  All normalized spectra from each kind of raft at each time point were 
averaged, and these means were compared at each wavenumber with simple one-way 
ANOVA and/or a series of 2-sample t-tests.  More complicated techniques often used 
with Raman spectra were deemed unnecessary since we are not trying to develop a 
discrimination algorithm, but rather we are examining the spectra for qualitative and 
simple, significant quantitative differences.  The spectra for each kind of raft were also 
averaged over all the time points for a particular study or over multiple studies and 
examined in a similar fashion.   
 
Results 
 Figure 2.2 below shows the means of all spectra taken in the initial study, which 
featured only normal rafts and rafts with SCC cells in the stroma layer at varying 
concentrations.  The signal below 1000 cm-1 is not shown due to the presence of silica 
peaks from the fiber optics obscuring any useful biological peaks.  A simple visual 
inspection targeted the area from about 1300 to 1350 cm-1 as an area of possible 
discrimination between normal and dysplastic rafts.  A series of t-tests comparing the  
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Figure 2.2  Mean Raman spectra for all time points of initial study for normal rafts (n=18 
measurements), and dysplastic rafts with SCC cells at concentrations of 1x (n=18), .2x 
(n=6), .4x (n=6), and .6x (n=6) relative to that of NHDF cells. 
 
 
 
normal rafts with each set of dysplastic rafts at each wavenumber confirmed this 
observation, giving a significant result at the 0.005 significance level for each comparison 
over the 1305 to 1330 cm-1 range, and nowhere else.  It is unclear from the figure whether 
there is a SCC cell concentration-dependent effect on the signal.  No single concentration 
tested significantly different from all the other concentrations in a series of t tests at any 
wavenumber, so we concluded that if such an effect exists, it is not significant. 
 For individual time points of the initial study, day 5 showed little differentiation 
among the different kinds of rafts.  Days 12 and 26 showed a visual, but not statistically 
significant, discrimination.  Figure 2.3 shows the spectra obtained at day 19, which again 
shows a visual distinction between the normal and dysplastic rafts around 1300 to 1350 
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cm-1.  From a series of t-tests at the .01 significance level, the peak at 1450 cm-1 is 
significantly different between normal and dysplastic rafts, as is the shoulder region from 
1304 to 1320 cm-1.  At the .005 significance level, only the minor peak around 1307 – 
1310 cm-1 remains significantly different between normal and dysplastic rafts.  In this 
case, a visual inspection is enough to conclude that no concentration-dependent effect on 
the signal is present. 
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Figure 2.3  Mean Raman spectra for day 19 of initial study for normal rafts (n=4 
measurements), and dysplastic rafts with SCC cells at concentrations  of 1x (n=4), .2x 
(n=2), .4x (n=2), and .6x (n=2). 
 
 
 Based on the results above, a more standardized procedure was developed and 
used for the remainder of the studies.  Figure 2.4 shows the progression of Raman spectra 
obtained during a single series of experiments at days 10, 15, and 20 following the  
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Figure 2.4  Progression of Raman spectra obtained from rafts at (A) 10, (B) 15, and (C) 
20 days in a single experiment.  For each line, n = 2 measurements from each of 4 rafts. 
 
 
transfer to the air-liquid interface.  Each line represents the average spectrum from two 
measurements each on four samples of each kind of raft.  Focusing on the same spectral 
region as before, at days 10 and 15, there is little difference between normal rafts and 
rafts with SCC cells in the stroma, but there is a significant difference (p < .01) between 
rafts with SCC cells in the epidermis and all other rafts.  There are differences in other 
spectral regions, but 1300 to 1330 cm-1 shows the most.  At day 20, however, all rafts 
with dysplastic cells in any location gave equivalent Raman spectral signatures that were 
significantly different (p < .001) from those of normal rafts in the 1300 to 1330 cm-1 
range, and in the shoulder regions from about 1070 to 1100 cm-1 and 1110 to 1130 cm-1.   
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 Since Raman spectra obtained at day 20 tended to show the most distinction 
between normal and all dysplastic rafts, measurements from day 20 of three different sets 
of experiments were combined to produce Figure 2.5 below.  Each plot now represents  
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Figure 2.5  Mean Raman spectra taken on day 20 of rafts from three sets of experiments.  
For each line, n = 2 measurements from each of 12 rafts. 
 
 
 
the mean of two measurements from each of 12 rafts.  Fewer wavenumbers show 
significant differences in this figure, but given the increase in sample size, the region 
from 1300 to 1320 cm-1 still shows a significant difference (p < .01) between the normal 
rafts and any type of cancerous raft, while all dysplastic rafts are statistically equivalent. 
 Raman spectra from the epidermal layer only, taken on day 20, were also 
averaged over three sets of experiments and are shown in Figure 2.6.  Since some rafts  
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Figure 2.6  Mean Raman spectra of epidermis only, taken on day 20, of rafts from three 
sets of experiments.  For each line, n = 2 measurements from each of 8 rafts. 
 
 
were saved intact for histology, each plot represents the mean of two measurements on 
each of eight raft epidermal layers that had been separated from the underlying stroma.  
This figure appears somewhat unusual at first, especially with regard to intensity 
differences, but all spectra were normalized over their entire range, which includes 
portions not shown in the figure.  Considering the spectra as displayed produces 
significant differences across most of the wavenumbers between normal rafts and those 
with SCC cells in any location, while the epidermal layers of the rafts with SCC cells 
only in their stroma were mostly equivalent to one another but different from the other 
two types.  If only this portion of the spectra were re-normalized to eliminate intensity 
differences (not shown), we find that epidermal Raman signatures from normal rafts are 
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still significantly different (p < .01) from all other raft types, and now the epidermal 
signatures from rafts with SCC cells originally in the stroma only or in the epidermis only 
are mostly equivalent, including in the 1300 to 1330 cm-1 region.  These findings can be 
seen simply by eye-balling the general line shapes while ignoring intensity differences in 
Figure 2.6 as well – the epidermal signatures from the three dysplastic rafts all appear to 
be quite similar to each other but different from the normal one. 
 The relationships among the mean Raman signatures of the epidermal and stromal 
layers of the same set of rafts are shown in more detail in Figure 2.7 below.  
Representative histological images of the different kinds of rafts are shown in Figure 2.8 
as well.  From Figure 2.7(A and B), we see that the stromal signatures of normal rafts and 
rafts with SCC cells only in the epidermis appear to be nearly identical, and these layers 
look very similar under standard histology in Figure 2.8(A and B).  The stromal 
signatures of the two types of rafts with SCC cells only in the dermis, as seen in Figure 
2.7(C and D), are also nearly identical, as were their histological findings, so only one 
example is shown in Figure 2.8(C).  The stromal signatures of rafts with normal dermis 
layers were significantly different (p < .01), though, compared with the stromal 
signatures of the rafts with cancerous dermis layers, as expected.  As seen when 
comparing the top row of Figure 2.7 to the bottom row, this difference is again primarily 
in the region of 1300 to 1320 cm-1.   
 Figure 2.7 supports the idea reported in our earlier study39 that much of the 
spectral variation in intact raft cultures derives from the epidermal layer, since there are 
much greater differences in the epidermal signatures among the different kinds of rafts 
compared with the stromal signatures.  Figure 2.8 brings up an interesting point about the 
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Figure 2.7  Mean Raman spectra over same three sets of experiments, taken at day 20, 
comparing stromal and epidermal signatures of (A) normal, (B) SCC epi, (C) SCC str 1x, 
and (D) SCC str .5x rafts. 
 
 
spectral variations of the epidermal layers seen in Figures 2.6 and 2.7.  The epidermis of 
2.8(C) does not visually look like the epidermis of 2.8(B), but spectrally, they are nearly 
equivalent.  The pockets of SCC cells in the dermis of 2.8(C) do closely resemble the 
dysplastic epidermis of 2.8(B). The epidermis of 2.8(C) looks similar to, but not exactly 
like the normal one in 2.8(A), which is due at least in part to difficulties processing raft 
cultures for histology without damaging them, but they are spectrally distinct. 
36 
    (A)             (B) 
 
          
SC 
 
 
   E        E 
 
 
 
 
    D         
 
               D 
 
      (C) 
 
   SC 
 
   E 
                 
 
   D  
 
 
 
 
 
Figure 2.8  Representative histological images of (A) normal raft, (B) raft with SCC cells 
in epidermis and normal stroma, and (C) raft with SCC cells in stroma and initially 
normal epidermis.  SC, stratum corneum; E, other epidermis; D, dermis (stroma) 
 
 
Discussion 
 The results of this study agree fairly well with what was expected.  The results 
seen in Figures 2.2 and 2.3 first demonstrated that when gathering Raman spectra with a 
macroscopic probe able to penetrate several hundred microns, the location of the 
cancerous cells does not significantly impact the signatures.  Visually, figure 2.2 hinted at 
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a dose-dependant effect, but further studies and statistical analysis have indicated that, at 
least within the ranges used, concentration of SCC cells in the dermis is not a major 
factor in determining the Raman spectral shape.  The same spectral region, approximately 
1300 to 1330 cm-1, showed the greatest differences between normal and dysplastic rafts 
both in our previous study39 and in this study.  The peaks in this spectral region can be 
attributed to a variety of molecules – lipids, proteins (amide III band), and DNA 
nucleotide bases.  All of these molecules would be expected to be present in higher 
concentrations in cancerous vs. normal tissue, especially DNA, thus explaining the 
increase in Raman intensities in that region.  The peak around 1450 cm-1 can sometimes 
be useful for tissue discrimination as well, as in Figure 2.3, as it gives information about 
the relative contents of lipid and protein. 
 As demonstrated in Figure 2.4, the best results for distinguishing diseased from 
normal tissue seemed to be measurements taken at 20 days following the transfer of the 
rafts to the air-liquid interface.  Rafts need about two weeks to fully develop, so this time 
frame seems reasonable for the maturation of keratinocytes and progression of SCC cells.  
Differentiated keratinocytes in the body tend to undergo apoptosis after about three 
weeks, which may explain why no useful data was able to be obtained past 20 days.  SCC 
cells deposited in the stroma showed an interesting pattern of growth.  Although we do 
not have histology exactly corresponding to the spectra in Figure 2.4, other experiments 
showed that the SCC cells were initially spread out fairly evenly with the fibroblasts, then 
began to gather in bunches as depicted in Figure 2.8(C), increase in number, and actually 
move toward the top of the dermis to some extent.  This progression of events could 
certainly be the mechanism behind the spectral changes going from (A) to (C) in Figure 
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2.4.  These results were also some of the first to demonstrate that Raman spectra obtained 
side-by-side from rafts with SCC cells seeded in either the epidermis or the dermis were 
equivalent, rather than relying on comparing these results to older ones. 
 The importance of Figure 2.5 is that we can still distinguish between normal and 
dysplastic rafts of any type when data from three different experiments are combined, 
using the same spectral region as before.  Although there will always be slight 
inconsistencies between different batches of raft cultures, these results indicate that their 
construction, even with introducing SCC cells into the dermis, is fairly reproducible.  
This figure also indicates that this simple t-test at every wavenumber may not be 
appropriate for looking at larger amounts of data in cases where inherent variability 
masks out significant differences within individual time points. 
 As mentioned, Figures 2.6 and 2.7 can be interpreted in multiple ways.  The 
Raman spectra from separated stroma layers are all fairly similar, though the rafts with 
SCC cells in the stroma do show an increase in the intensity of the 1307 cm-1 DNA 
shoulder off of the 1270 cm-1 peak, primarily due to collagen, relative to rafts with 
normal stroma.  It is fairly easy to visualize how the combinations of epidermis and 
dermis signal from each part of 2.7 would combine to form the spectra seen in 2.4(C).  
One might expect greater differences in the stroma signatures, though perhaps signal 
from malignant cells deeper in the tissue is not collected as efficiently, or maybe it is an 
issue of beam geometry in not having the highly scattering epidermis above it to 
effectively spread out the photons and detect more cancerous cells. 
 The differences in spectral signatures from the epidermis layers only are more 
dramatic.  Whether or not one believes that the observed general intensity differences are 
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a real effect, it is hard to argue with the line shapes, especially upon re-normalization, 
given that these results were seen in three different sets of experiments.  The equivalence 
of epidermal spectra from rafts with SCC cells initially in just the epidermis or just the 
stroma, along with their nonequivalence with epidermal spectra from normal rafts, backs 
up our previous in vivo skin study and again suggests the ability of Raman spectroscopy 
to detect malignancy associated changes in a tissue prior to it actually becoming 
cancerous.  Figure 2.8(C) shows that the epidermis of the "SCC stroma" raft clearly does 
not visually resemble that of the "SCC epi" raft in 2.8(B), but does more closely resemble 
the epidermis of the normal raft in 2.8(A).  Unfortunately, raft cultures are notoriously 
difficult materials to process for histology, which has prevented our obtaining better 
pictures of rafts with SCC cells in the stroma to help either prove or disprove our case.  It 
certainly appears, though, that when the SCC cells are seeded in the stroma, they produce 
some sort of biochemical signal that both draws them together in clusters and influences 
the epidermal cells above them to undergo changes that are detectable with Raman  
spectroscopy, but not with a standard histology preparation.  The development of these 
signals is another possible explanation for the time course seen in Figure 2.4. 
 Several points still need to be addressed with this study.  Raft cultures are good 
models of skin, both structurally and spectroscopically, but they are not perfect.  There 
are no blood vessels or inflammatory cells in the dermis, and there is no basement 
membrane between the epidermis and dermis.  The latter fact may be relevant in this case 
not only because of a missing component that may contribute to in vivo Raman, but also 
because its presence may affect the transmission of any biochemical signals between the 
dermis and epidermis.  More consistency still needs to be achieved between different 
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batches of rafts as well.  Instrumentation issues have prevented the gathering of useful 
depth-resolved data on intact rafts, which would be a solid piece of supporting evidence 
for these findings and for the in vivo skin findings.  
 In conclusion, we have demonstrated the ability to use Raman spectroscopy to 
distinguish between normal and dysplastic raft cultures regardless of where the SCC cells 
are located, and that the presence of disease in the stroma can be detected in the 
epidermis.  The signals obtained from the rafts with the macroscopic probe system are 
fairly well understood, but more study with confocal Raman spectroscopy and better 
histology is required to truly understand the depth-dependent basis of the signals.  
Although these raft cultures are not perfect models of skin or skin cancer, they have been 
shown to provide valuable information that will be useful for the concurrent in vivo 
studies on diagnosing nonmelanoma skin cancers. 
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CHAPTER IV 
 
SUMMARY AND RECOMMENDATIONS 
 
Summary 
 I set out my objectives and specific aims in a brief first chapter, and the second 
chapter presented a wealth of background information on skin cancer and on the 
principles and uses of optical spectroscopy, primarily Raman.  In the manuscript, we have 
demonstrated that Raman spectroscopy can distinguish between normal and dysplastic 
raft cultures regardless of where the SCC cells are located and their seeding densities.  
We showed that the presence of disease in the stroma can be detected in the epidermis, 
even when the epidermis still looks normal with standard histology.  These findings 
support our earlier in vivo skin study and offer additional evidence for the ability of 
spectroscopy to detect pre-malignant changes. 
 
Recommendations for future work 
 Several points still need to be addressed with this study.  Raft cultures are good 
models of skin, but they are not perfect.  There are no blood vessels or inflammatory cells 
in the dermis, and there is no basement membrane between the epidermis and dermis.  
Improving the raft model by introducing more components may provide better spectral 
characteristics, though it may not be worth the added complexity.  More consistency still 
needs to be achieved between different batches of rafts as well.  Instrumentation and 
other issues have prevented the gathering of useful depth-resolved data on intact rafts, 
45 
which would be a solid piece of supporting evidence for these findings and for the in vivo 
skin findings.  Better methods to ensure quality histological images of raft cultures would 
provide a benefit to this study as well. 
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